UroVysion, urine cytology, and the College of American Pathologists where should we go from here?

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 8, 2010, Pages 1106-1107

  Renshaw, Andrew A ^a  

^a BAPTIST HOSPITAL OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER TUMOR; CLINICAL TRIAL; CYTODIAGNOSIS; CYTOLOGY; FOOD AND DRUG ADMINISTRATION; HEMATURIA; HUMAN; MEDICAL EDUCATION; MEDICAL SOCIETY; PATHOLOGY; PREDICTION AND FORECASTING; REVIEW; STANDARD; TRANSITIONAL CELL CARCINOMA; UNITED STATES; URINALYSIS; URINE; UROTHELIUM;

CARCINOMA, TRANSITIONAL CELL; CLINICAL TRIALS AS TOPIC; CYTODIAGNOSIS; EDUCATION, MEDICAL, CONTINUING; HEMATURIA; HUMANS; PREDICTIVE VALUE OF TESTS; SOCIETIES, MEDICAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; URINALYSIS; URINARY BLADDER NEOPLASMS; URINE; UROTHELIUM;

EID: 77955386522     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Halling KC, King W, Sokolova IA, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol. 2000;164(5):1768-1775.
2. Halling KC. Vysis Urovysion for the detection of urothelial carcinoma. Expert Rev Mol Diagn. 2003;3(4):507-519.
3. Skacel M, Pettay JD, Tsifitsakis EK, Procop GW, Biscotti CV, Tubbs RR. Validation of multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid based cytology slides. Anal Quant Cytol Histol. 2001;23(6):381-387.
4. Bubendorf L, Grilli B, Sauter G, Mihatsch MJ, Gasser TC, Dalquen P. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol. 2001;116(1):79-86.
5. Veeramachaneni R, Nordberg ML, Shi R, Herrera ML, Turbat-Herrera EA. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol. 2003;28(6):301-307.
6. Halling KC, King W, Sokolova IA, et al. A comparison of BTA Stat, hemoglobin dipstick, telomerase and Vysis Orovysion assays for the detection of urothelial carcinoma in urine. J Urol. 2002;167(5):2001-2006.
7. Friedrich MG, Toma MI, Hellstern A, et al. Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer. BJU Int. 2003;92(9):911-914.
8. Skacel M, Fahmy M, Brainard JA, et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol. 2003;169(6):2101-2105.
9. Marin-Aguilera M, Mengual L, Ribal MJ, et al. Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol. 2007;51(2):409-415.
10. Zellweger T, Benz G, Cathomas G, et al. Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer. 2006;119(7):1660-1665.
11. Ferra S, Denley R, Herr H, Dalbagni G, Jhanwar S, Lin O. Reflex Urovysion testing suspicious urine cytology cases. Cancer Cytopathol. 2009;117(1):7-14.
12. Sullivan PS, Nooraie F, Sanchez H, et al. Comparison of Immunocyt, Urovysion, and urine cytology in detection of recurrent urothelial carcinoma: a split sample study. Cancer Cytopathol. 2009;117(3):167-173.
13. Hajdinjak T. Urovysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. Urol Oncol. 2008;26(6):646-651.
14. Halling KC, Kipp BR. Bladder cancer detection using FISH (UroVysion assay). Adv Anat Pathol. 2008;15(5):279-286.
15. Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM. The accuracy of urinary cytology in daily practice. Cancer Cytopathol. 1999;87:118-128.
16. Daniely M, Rona R, Kaplan T, et al. Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples. Urology. 2005;66(6):1354-1359.
17. Halling KC, Kipp BR. Fluorescence in situ hybridisation for the detection of bladder cancer. Eur Ren Genitourinary Dis. 2006;2:51-54.
18. Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Abara EO, Barkin J. Evaluation of a multi-target fluorescent in situ hybridization (FISH) assay in the initial diagnosis of bladder cancer in patients with hematuria [abstract]. J Urol. 2005;171 S: 252.
19. Yoder BJ, Skacel M, Hedgepeth R, et al. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology. Am J Clin Pathol. 2007;127(2):295-301.